Screener
ADMA Biologics ADMA Plasma Collection Centers — Nonoperating Income Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| (in thousands) | ADMA Bio Manufacturing | Plasma Collection Centers | Total |
|---|---|---|---|
| Selling, marketing and distribution | 7,634 | - | 7,634 |
| Depreciation and amortization expense | 1,281 | 499 | 1,780 |
| General and administrative expense | 8,340 | - | 8,340 |
| Other income (expense), net | (20) | 150 | 130 |
| Income (loss) before taxes | 64,010 | (707) | 63,303 |
| Expenditures for additions to long-lived assets | 2,256 | - | 2,256 |
| Total assets | 453,538 | 21,864 | 475,402 |
| Reconciliation of revenues: |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's plasma collection centers — nonoperating income expense?
- ADMA Biologics (ADMA) reported plasma collection centers — nonoperating income expense of $150K in Q2 2026.
- What does plasma collection centers — nonoperating income expense mean?
- Includes financial items not related to the core plasma collection operations, such as interest income, interest expense, or foreign exchange gains and losses. This metric isolates the impact of financing and peripheral activities from the segment's primary business performance. It is essential for understanding the segment's net contribution to the company's bottom line.
Ask your AI about ADMA Biologics's plasma collection centers — nonoperating income expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude